Determining the Relationship Between the Atherosclerosis and Periodontopathogenic Microorganisms
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Determine the relationship between the systemic indications of atherosclerosis by means of the change in the ratio of periodontopathogenic microorganisms following periodontal treatment of individuals who have been diagnosed with chronic periodontitis-atherosclerosis and for individuals who have been diagnosed with systemically healthy-chronic periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 15, 2016
CompletedFirst Posted
Study publicly available on registry
November 30, 2016
CompletedNovember 30, 2016
November 1, 2016
1 year
November 15, 2016
November 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Periodontopathogenic microorganism levels
1 year
Study Arms (2)
Atherosclerosis
EXPERIMENTALPatients with atherosclerosis and chronic periodontitis
Systemically healthy
ACTIVE COMPARATORPatients with Systemically healthy and chronic periodontitis.
Interventions
Eligibility Criteria
You may qualify if:
- had no systemic disease,
- had not used any antibiotics
- had not used medications with an impact on the immune system,
- had not received any periodontal and/or medical treatment within the last 6 months.
You may not qualify if:
- smokers of cigarettes or other tobacco products,
- pregnant or breastfeeding,
- non-stable cardiovascular condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 15, 2016
First Posted
November 30, 2016
Study Start
January 1, 2014
Primary Completion
January 1, 2015
Study Completion
January 1, 2016
Last Updated
November 30, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share